Elimination of Granulocytic Myeloid-Derived Suppressor Cells in Lupus-Prone Mice Linked to Reactive Oxygen Species-Dependent Extracellular Trap Formation

Arthritis and Rheumatology

Volumn 68, Issue 2, 2016, Pages 449-461

  Vlachou, Katerina ^a,b,e   Mintzas, Konstantinos ^b   Glymenaki, Maria ^b   Ioannou, Marianna ^b   Papadaki, Garyfalia ^b   Bertsias, George K ^b   Sidiropoulos, Prodromos ^b   Boumpas, Dimitrios T ^a,c,e   Verginis, Panayotis ^d,e  

^a INSTITUTE OF COMPUTER SCIENCE   (Greece)

^b UNIVERSITY OF CRETE   (Greece)

^c UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^d DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^e BIOMEDICAL RESEARCH FOUNDATION   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; GAMMA INTERFERON; INTERLEUKIN 6; REACTIVE OXYGEN METABOLITE; CYTOKINE; LY ANTIGEN; LY6G ANTIGEN, MOUSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOIMMUNITY; CELL EXPANSION; CELL FUNCTION; CONFOCAL MICROSCOPY; CONTROLLED STUDY; EXTRACELLULAR TRAP; FEMALE; FLOW CYTOMETRY; FLUORESCENCE ACTIVATED CELL SORTING; IMMUNOFLUORESCENCE; IMMUNOPATHOGENESIS; IN VITRO STUDY; INFANT; LYMPHOCYTE PROLIFERATION; LYMPHOID ORGAN; MALE; MOUSE; MYELOID DERIVED SUPPRESSOR CELL; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEINURIA; QUANTITATIVE STUDY; REAL TIME POLYMERASE CHAIN REACTION; SUPPRESSOR CELL; SYSTEMIC LUPUS ERYTHEMATOSUS; ANIMAL; BONE MARROW CELL; C57BL MOUSE; CELL PROLIFERATION; DISEASE MODEL; DISEASE PREDISPOSITION; FLUORESCENT ANTIBODY TECHNIQUE; GRANULOCYTE PRECURSOR; IMMUNOLOGY; NEW ZEALAND BLACK MOUSE; T LYMPHOCYTE;

ANIMALS; ANTIGENS, LY; CELL PROLIFERATION; CYTOKINES; DISEASE MODELS, ANIMAL; DISEASE SUSCEPTIBILITY; EXTRACELLULAR TRAPS; FEMALE; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE; GRANULOCYTE PRECURSOR CELLS; IN VITRO TECHNIQUES; INTERFERON-ALPHA; INTERFERON-GAMMA; INTERLEUKIN-6; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MICE; MICE, INBRED C57BL; MICE, INBRED NZB; MICROSCOPY, CONFOCAL; MYELOID CELLS; REACTIVE OXYGEN SPECIES; REAL-TIME POLYMERASE CHAIN REACTION; T-LYMPHOCYTES;

EID: 84956813824     PISSN: 23265191     EISSN: 23265205     Source Type: Journal    
DOI: 10.1002/art.39441     Document Type: Article

References (50)

1. Tsokos GC., Systemic lupus erythematosus [review]. N Engl J Med 2011; 365: 2110-21.
2. Wahren-Herlenius M, Dorner T., Immunopathogenic mechanisms of systemic autoimmune disease [review]. Lancet 2013; 382: 819-31.
3. Kaplan MJ., Neutrophils in the pathogenesis and manifestations of SLE [ review]. Nat Rev Rheumatol 2011; 7: 691-9.
4. Ren Y, Tang J, Mok MY, Chan AW, Wu A, Lau CS., Increased apoptotic neutrophils and macrophages and impaired macrophage phagocytic clearance of apoptotic neutrophils in systemic lupus erythematosus. Arthritis Rheum 2003; 48: 2888-97.
5. + cells and impaired function of bone marrow stromal cells in patients with systemic lupus erythematosus. Br J Haematol 2001; 115: 167-74.
6. low neutrophils provide a quantitative index of active bone marrow neutrophil release [published erratum appears in Br J Haematol 2006;132:533]. Br J Haematol 2005; 131: 508-19.
7. Lande R, Ganguly D, Facchinetti V, Frasca L, Conrad C, Gregorio J, et al., Neutrophils activate plasmacytoid dendritic cells by releasing self-DNA-peptide complexes in systemic lupus erythematosus. Sci Transl Med 2011; 3: 73ra19.
8. Nakou M, Knowlton N, Frank MB, Bertsias G, Osban J, Sandel CE, et al., Gene expression in systemic lupus erythematosus: bone marrow analysis differentiates active from inactive disease and reveals apoptosis and granulopoiesis signatures. Arthritis Rheum 2008; 58: 3541-9.
9. Denny MF, Yalavarthi S, Zhao W, Thacker SG, Anderson M, Sandy AR, et al., A distinct subset of proinflammatory neutrophils isolated from patients with systemic lupus erythematosus induces vascular damage and synthesizes type I IFNs. J Immunol 2010; 184: 3284-97.
10. Gabrilovich DI, Nagaraj S., Myeloid-derived suppressor cells as regulators of the immune system [ review]. Nat Rev Immunol 2009; 9: 162-74.
11. Ioannou M, Alissafi T, Lazaridis I, Deraos G, Matsoukas J, Gravanis A, et al., Crucial role of granulocytic myeloid-derived suppressor cells in the regulation of central nervous system autoimmune disease. J Immunol 2012; 188: 1136-46.
12. Fujii W, Ashihara E, Hirai H, Nagahara H, Kajitani N, Fujioka K, et al., Myeloid-derived suppressor cells play crucial roles in the regulation of mouse collagen-induced arthritis. J Immunol 2013; 191: 1073-81.
13. Yin B, Ma G, Yen CY, Zhou Z, Wang GX, Divino CM, et al., Myeloid-derived suppressor cells prevent type 1 diabetes in murine models. J Immunol 2010; 185: 5828-34.
14. Guan Q, Moreno S, Qing G, Weiss CR, Lu L, Bernstein CN, et al., The role and potential therapeutic application of myeloid-derived suppressor cells in TNBS-induced colitis. J Leukoc Biol 2013; 94: 803-11.
15. Morel L, Wakeland EK., Susceptibility to lupus nephritis in the NZB/W model system [review]. Curr Opin Immunol 1998; 10: 718-25.
16. Papayannopoulos V, Metzler KD, Hakkim A, Zychlinsky A., Neutrophil elastase and myeloperoxidase regulate the formation of neutrophil extracellular traps. J Cell Biol 2010; 191: 677-91.
17. Marigo I, Bosio E, Solito S, Mesa C, Fernandez A, Dolcetti L, et al., Tumor-induced tolerance and immune suppression depend on the C/EBPβ transcription factor. Immunity 2010; 32: 790-802.
18. Rodriguez PC, Ochoa AC., Arginine regulation by myeloid derived suppressor cells and tolerance in cancer: mechanisms and therapeutic perspectives [ review]. Immunol Rev 2008; 222: 180-91.
19. Bronte V, Serafini P, Mazzoni A, Segal DM, Zanovello P., L-arginine metabolism in myeloid cells controls T-lymphocyte functions [review]. Trends Immunol 2003; 24: 302-6.
20. Howie JB, Helyer BJ., The immunology and pathology of NZB mice [review]. Adv Immunol 1968; 9: 215-66.
21. Helyer BJ, Howie JB., Renal disease associated with positive lupus erythematosus tests in a cross-bred strain of mice. Nature 1963; 197: 197.
22. Goldmann O, Medina E., The expanding world of extracellular traps: not only neutrophils but much more [review]. Front Immunol 2012; 3: 420.
23. Remijsen Q, Vanden Berghe T, Wirawan E, Asselbergh B, Parthoens E, De Rycke R, et al., Neutrophil extracellular trap cell death requires both autophagy and superoxide generation. Cell Res 2011; 21: 290-304.
24. Ponpuak M, Davis AS, Roberts EA, Delgado MA, Dinkins C, Zhao Z, et al., Delivery of cytosolic components by autophagic adaptor protein p62 endows autophagosomes with unique antimicrobial properties. Immunity 2010; 32: 329-41.
25. Ohl K, Tenbrock K., Inflammatory cytokines in systemic lupus erythematosus. J Biomed Biotechnol 2011; 2011: 432-595.
26. Sakaguchi S, Yamaguchi T, Nomura T, Ono M., Regulatory T cells and immune tolerance [review]. Cell 2008; 133: 775-87.
27. Littman DR, Rudensky AY., Th17 and regulatory T cells in mediating and restraining inflammation [review]. Cell 2010; 140: 845-58.
28. Grant CR, Liberal R, Mieli-Vergani G, Vergani D, Longhi MS., Regulatory T-cells in autoimmune diseases: challenges, controversies and-yet-unanswered questions [review]. Autoimmun Rev 2015; 14: 105-16.
29. Lee JH, Wang LC, Lin YT, Yang YH, Lin DT, Chiang BL., Inverse correlation between CD4+ regulatory T-cell population and autoantibody levels in paediatric patients with systemic lupus erythematosus. Immunology 2006; 117: 280-6.
30. + regulatory T-cells in human systemic lupus erythematosus. J Formos Med Assoc 2012; 111: 465-70.
31. Azab NA, Bassyouni IH, Emad Y, Abd El-Wahab GA, Hamdy G, Mashahit MA., CD4+CD25+ regulatory T cells (TREG) in systemic lupus erythematosus (SLE) patients: the possible influence of treatment with corticosteroids. Clin Immunol 2008; 127: 151-7.
32. Cripps JG, Gorham JD., MDSC in autoimmunity [review]. Int Immunopharmacol 2011; 11: 789-93.
33. high CD11b+ cells suppress B cell differentiation and lupus-like disease in lupus-prone male mice. Arthritis Rheum 2013; 65: 2392-402.
34. + cells suppress T-dependent antibody responses in (NZB × NZW)F1 male mice through inhibition of T follicular helper cells and germinal center formation. J Immunol 2014; 192: 1570-6.
35. Brinkmann V, Reichard U, Goosmann C, Fauler B, Uhlemann Y, Weiss DS, et al., Neutrophil extracellular traps kill bacteria. Science 2004; 303: 1532-5.
36. Fuchs TA, Abed U, Goosmann C, Hurwitz R, Schulze I, Wahn V, et al., Novel cell death program leads to neutrophil extracellular traps. J Cell Biol 2007; 176: 231-41.
37. Von Kockritz-Blickwede M, Goldmann O, Thulin P, Heinemann K, Norrby-Teglund A, Rohde M, et al., Phagocytosis-independent antimicrobial activity of mast cells by means of extracellular trap formation. Blood 2008; 111: 3070-80.
38. Yousefi S, Gold JA, Andina N, Lee JJ, Kelly AM, Kozlowski E, et al., Catapult-like release of mitochondrial DNA by eosinophils contributes to antibacterial defense. Nat Med 2008; 14: 949-53.
39. Morshed M, Hlushchuk R, Simon D, Walls AF, Obata-Ninomiya K, Karasuyama H, et al., NADPH oxidase-independent formation of extracellular DNA traps by basophils. J Immunol 2014; 192: 5314-23.
40. Villanueva E, Yalavarthi S, Berthier CC, Hodgin JB, Khandpur R, Lin AM, et al., Netting neutrophils induce endothelial damage, infiltrate tissues, and expose immunostimulatory molecules in systemic lupus erythematosus. J Immunol 2011; 187: 538-52.
41. Garcia-Romo GS, Caielli S, Vega B, Connolly J, Allantaz F, Xu Z, et al., Netting neutrophils are major inducers of type I IFN production in pediatric systemic lupus erythematosus. Sci Transl Med 2011; 3: 73ra20.
42. Knight JS, Zhao W, Luo W, Subramanian V, O'Dell AA, Yalavarthi S, et al., Peptidylarginine deiminase inhibition is immunomodulatory and vasculoprotective in murine lupus. J Clin Invest 2013; 123: 2981-93.
43. Tsuda Y, Takahashi H, Kobayashi M, Hanafusa T, Herndon DN, Suzuki F., Three different neutrophil subsets exhibited in mice with different susceptibilities to infection by methicillin-resistant Staphylococcus aureus. Immunity 2004; 21: 215-26.
44. Fridlender ZG, Sun J, Kim S, Kapoor V, Cheng G, Ling L, et al., Polarization of tumor-associated neutrophil phenotype by TGF-β: "N1" versus "N2" TAN. Cancer Cell 2009; 16: 183-94.
45. Pillay J, Tak T, Kamp VM, Koenderman L., Immune suppression by neutrophils and granulocytic myeloid-derived suppressor cells: similarities and differences [review]. Cell Mol Life Sci 2013; 70: 3813-27.
46. Perazzio SF, Salomao R, Silva NP, Andrade LE., Increased neutrophil oxidative burst metabolism in systemic lupus erythematosus. Lupus 2012; 21: 1543-51.
47. Bengtsson AA, Pettersson A, Wichert S, Gullstrand B, Hansson M, Hellmark T, et al., Low production of reactive oxygen species in granulocytes is associated with organ damage in systemic lupus erythematosus. Arthritis Res Ther 2014; 16: R120.
48. Zhang X, Majlessi L, Deriaud E, Leclerc C, Lo-Man R., Coactivation of Syk kinase and MyD88 adaptor protein pathways by bacteria promotes regulatory properties of neutrophils. Immunity 2009; 31: 761-71.
49. Holmstrom KM, Finkel T., Cellular mechanisms and physiological consequences of redox-dependent signalling [review]. Nat Rev Mol Cell Biol 2014; 15: 411-21.
50. Condamine T, Gabrilovich DI., Molecular mechanisms regulating myeloid-derived suppressor cell differentiation and function [review]. Trends Immunol 2011; 32: 19-25.